These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Vasorelaxant and platelet-suppressant potencies of four NO-donors.
    Author: Zembowicz A, Dudek RD, Radziszewski W, Swierkosz TA, Trybulec M, Gryglewski RJ.
    Journal: Pol J Pharmacol Pharm; 1990; 42(3):275-81. PubMed ID: 2124687.
    Abstract:
    Rabbit aortic strips were arranged in a Vane's cascade and superfused with Krebs buffer which contained phenylephrine hydrochloride (100 nM) and indomethacin (5 microM). EC50 (nM) for vasorelaxant action of NO-donors on rabbit aortic strips were as follows: glyceryl trinitrate--64.0, sodium nitroprusside--124.5, S-nitroso-N-acetylpenicillamine--305.7, SIN-1 (metabolite of molsidomine)--510.0. On the other hand IC50 (microM) for antiaggregatory action of NO-donors in human platelet rich plasma aggregated with threshold concentrations of collagen (0.5-1 micrograms/ml) were as follows: S-nitroso-N-acetylpenicillamine--7,1, SIN-1--13.6, sodium nitroprusside--28.0. Glyceryl trinitrate did not inhibit platelet aggregation at concentrations up to 1 mM. Sodium nitroprusside was more specific (EC50/IC50 = 0.0043) than SNAP and SIN-1 (EC50/IC50 = 0.043 and 0.037, respectively) as a vasorelaxant than as a platelet suppressant. Thus relative potencies of four c-GMP stimulants as vasorelaxants and platelet-suppressants differed considerably and several possible explanations for these differences were put forward.
    [Abstract] [Full Text] [Related] [New Search]